Juan Pablo Brito MD

Thyroid

Physician

200 1st Street SWRochester, MN 55905

Dr. Brito is on Doximity

As a Doximity member, you’ll join more than three million U.S. healthcare professionals—including 85+% of physicians, and 2/3 of all NPs and PAs—in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

See Dr. Brito's full profile Already have an account?

Education & Training

Mayo Clinic College of Medicine and Science (Rochester)Fellowship, Endocrinology, Diabetes, and Metabolism, 2011 - 2014
University of Miami/Jackson Health SystemResidency, Internal Medicine, 2008 - 2011
Universidad Central del Ecuador School of MedicineClass of 2005

The following disclaimer is related to board certifications obtained from ABMS®, denoted by the ABMS® logo.

This information is proprietary data maintained in a copyrighted database owned by the American Board of Medical Specialties®. The display and presence of ABMS Data in no way constitutes any affiliation, association with, or endorsement of any advertising, promotion, or sponsorship by ABMS and its affiliates and subsidiaries, the ABMS Member Boards, or ABMS board certified physicians and medical specialists. Copyright 2026 American Board of Medical Specialties®. All rights reserved.

The user is responsible for ensuring that the profile obtained in this directory is the profile of the physician or medical specialist being sought.

A self-designated specialty, subspecialty, or practice area neither implies nor is equivalent to ABMS board certification or the existence of specialized training by or competence of a physician or medical specialist.

Certifications & Licensure

MN State Medical License 2011 - 2027
American Board of Internal Medicine Internal Medicine
American Board of Internal Medicine Endocrinology, Diabetes and Metabolism

Awards, Honors, & Recognition

CMS Meaningful Use Stage 2 Certification Mayo Clinic Incorporate Lab Results, Mayo Clinic, 2014-2015, 2017
CMS Meaningful Use Stage 2 Certification Mayo Clinic Electronic Notes, Mayo Clinic, 2014-2015, 2017
CMS Meaningful Use Stage 1 Certification Centricity Enterprise, GE Healthcare, 2014-2015, 2017

Clinical Trials

Impact of Papillary Microcarcinoma Terminology on Patients Treatment Preferences: a Cross Sectional Survey
WITHDRAWN

Publications & Presentations

PubMed

Variation and potential overuse in thyroid ultrasound ordering: exploratory insights from a clinician survey.
Sualeha Khalid, Alexandria Ratzki-Leewing, Juan P Brito, Naykky Singh Ospina, Rozalina G McCoy
Endocrine. 2026-08-21
Patterns of TSH test after GLP-1 RAs initiation in patients on levothyroxine: a trial emulation study.
Yishan Chen, Fanxing Du, Naykky M Singh Ospina, Juan P Brito, Hui Shao
The Journal of Clinical Endocrinology and Metabolism. 2026-08-13
End-Organ Damage Associated With Primary Hyperparathyroidism.
Lia D Delaney, Heather S Day, Katherine D Arnow, Rozalina G McCoy, Juan P Brito
JAMA Surgery. 2026-07-29

Journal Articles

Comparative Effectiveness of Generic vs Brand-Name Levothyroxine in Achieving Normal Thyrotropin Levels
Juan P Brito, Robert C Smallridge, Victor Bernet, Kasia J Lipska, JAMA Network Open
Assessment of Shared Decision-Making for Stroke Prevention in Patients with Atrial Fibrillation
Takeki Suzuki, Erik Hess, Juan P Brito, Peter A Noseworthy, Victor M Montori, JAMA Internal Medicine
Patients’ Experiences of Diagnosis and Management of Papillary Thyroid Microcarcinoma: A Qualitative Study
Juan Brito, MD, BioMed Central

Press Mentions

Strategies Needed to Reduce Number of Unnecessary Thyroid UltrasoundsAugust 25th, 2025
GLP-1 RAs Tied to Higher Thyroid Cancer Risk in First Year of TreatmentJanuary 31st, 2025
HMN 2025: How Glucagon-like Peptide-1 Receptor Agonists Tied to Greater Thyroid Cancer Threat in First 12 Months of TherapyJanuary 31st, 2025

Grant Support

Addressing Thyroid Cancer Overdiagnosis: AI-Driven Identification, Characterization, and Outcomes of Incidental Thyroid NodulesMAYO CLINIC ROCHESTER2026–2031
Addressing Thyroid Cancer Overdiagnosis: AI-Driven Identification, Characterization, and Outcomes of Incidental Thyroid NodulesMAYO CLINIC ROCHESTER2026–2031
Understanding and addressing the lack of and delayed screening for primary AldosteronismMAYO CLINIC ROCHESTER2025–2028
De-implementation of inappropriate thyroid ultrasoundMAYO CLINIC ROCHESTER2022–2027
De-implementation of inappropriate thyroid ultrasoundMAYO CLINIC ROCHESTER2022–2027